Nitinotes Announces First Patient Treated in Pivotal Ease™ Clinical Trial

First patient treated in Nitinotes’ trial of EndoZip system for ESG

Nitinotes has commenced its US investigational device exemption (IDE) Endoscopic Automated Sleeve Evaluation (EASE) Clinical Trial, with the first patient treated using the EndoZip Automated Suturing System for endoscopic sleeve gastroplasty (ESG).The post First patient treated in Nitinotes’ trial of EndoZip system for ESG  appeared first on Medical Device Network.

First patient treated in EASE clinical trial evaluating the EndoZip Automated Suturing System for ESG

The first patient has been treated in Nitinotes’ US Investigational Device Exemption (IDE) EASE Clinical Trial evaluating the EndoZip Automated Suturing System for endoscopic sleeve gastroplasty (ESG). The procedure was performed at Lenox Hill Hospital | Northwell Health in New York, NY, the trial's first activated US site.The EASE Clinical Trial is a prospective, multi-centre, randomised, two-arm, blinded pivotal study designed to evaluate the …